Nir Naor - 06 Jan 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: CFO
Issuer ticker: AXGN
Reported as of: 06 Jan 2025
Net transaction value: -$595,589
SEC form: 4
Accepted by SEC: 06 Jan 2025, 18:39:06 UTC
Prior SEC filing: 03 Jan 2025
Next SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Nir Naor

Key filing fact

Nir Naor filed Form 4 for Axogen, Inc. (AXGN) on 06 Jan 2025.

Key facts

This page summarizes Nir Naor's Form 4 filing for Axogen, Inc. (AXGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jan 2025, 18:39.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: -$595,589.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Tax liability

Transaction value: $595,589
Shares: -39,132
Change %: -13%
Price: $15.22
Shares after: 260,868
Date: 06 Jan 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

The reported price in Column 4 is a weighted average sale price. These shares were sold on January 6, 2025 in multiple transactions at prices ranging from $14.37 to $15.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.